335 related articles for article (PubMed ID: 32156555)
41. Leptin signaling defects in a mouse model of Prader-Willi syndrome: An orphan genetic obesity syndrome no more?
Colmers WF; Wevrick R
Rare Dis; 2013; 1():e24421. PubMed ID: 25002992
[TBL] [Abstract][Full Text] [Related]
42. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
43. Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.
Miller JL; Gevers E; Bridges N; Yanovski JA; Salehi P; Obrynba KS; Felner EI; Bird LM; Shoemaker AH; Angulo M; Butler MG; Stevenson D; Abuzzahab J; Barrett T; Lah M; Littlejohn E; Mathew V; Cowen NM; Bhatnagar A;
J Clin Endocrinol Metab; 2023 Jun; 108(7):1676-1685. PubMed ID: 36639249
[TBL] [Abstract][Full Text] [Related]
44. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial.
Allas S; Caixàs A; Poitou C; Coupaye M; Thuilleaux D; Lorenzini F; Diene G; Crinò A; Illouz F; Grugni G; Potvin D; Bocchini S; Delale T; Abribat T; Tauber M
PLoS One; 2018; 13(1):e0190849. PubMed ID: 29320575
[TBL] [Abstract][Full Text] [Related]
45. Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review.
Pellikaan K; Nguyen NQC; Rosenberg AGW; Coupaye M; Goldstone AP; Høybye C; Markovic T; Grugni G; Crinò A; Caixàs A; Poitou C; Corripio R; Nieuwenhuize RM; van der Lely AJ; de Graaff LCG
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1720-e1730. PubMed ID: 37267430
[TBL] [Abstract][Full Text] [Related]
46. Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development.
Haqq AM; Grambow SC; Muehlbauer M; Newgard CB; Svetkey LP; Carrel AL; Yanovski JA; Purnell JQ; Freemark M
Clin Endocrinol (Oxf); 2008 Dec; 69(6):911-20. PubMed ID: 18710462
[TBL] [Abstract][Full Text] [Related]
47. Prader-Willi syndrome: an update on obesity and endocrine problems.
Kim SJ; Cho SY; Jin DK
Ann Pediatr Endocrinol Metab; 2021 Dec; 26(4):227-236. PubMed ID: 34991300
[TBL] [Abstract][Full Text] [Related]
48. Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain.
Lee S; Walker CL; Wevrick R
Gene Expr Patterns; 2003 Oct; 3(5):599-609. PubMed ID: 12971993
[TBL] [Abstract][Full Text] [Related]
49. Obesity management in Prader-Willi syndrome.
Salehi P; Leavitt A; Beck AE; Chen ML; Roth CL
Pediatr Endocrinol Rev; 2015 Mar; 12(3):297-307. PubMed ID: 25962207
[TBL] [Abstract][Full Text] [Related]
50. Hyperphagia in Prader-Willi syndrome with obesity: From development to pharmacological treatment.
Rahman QFA; Jufri NF; Hamid A
Intractable Rare Dis Res; 2023 Feb; 12(1):5-12. PubMed ID: 36873672
[TBL] [Abstract][Full Text] [Related]
51. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
[TBL] [Abstract][Full Text] [Related]
52. Paradoxical leanness in the imprinting-centre deletion mouse model for Prader-Willi syndrome.
Golding DM; Rees DJ; Davies JR; Relkovic D; Furby HV; Guschina IA; Hopkins AL; Davies JS; Resnick JL; Isles AR; Wells T
J Endocrinol; 2017 Jan; 232(1):123-135. PubMed ID: 27799465
[TBL] [Abstract][Full Text] [Related]
53. Muscle dysfunction caused by loss of Magel2 in a mouse model of Prader-Willi and Schaaf-Yang syndromes.
Kamaludin AA; Smolarchuk C; Bischof JM; Eggert R; Greer JJ; Ren J; Lee JJ; Yokota T; Berry FB; Wevrick R
Hum Mol Genet; 2016 Sep; 25(17):3798-3809. PubMed ID: 27436578
[TBL] [Abstract][Full Text] [Related]
54. Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome.
Adhikari A; Copping NA; Onaga B; Pride MC; Coulson RL; Yang M; Yasui DH; LaSalle JM; Silverman JL
Neurobiol Learn Mem; 2019 Nov; 165():106874. PubMed ID: 29800646
[TBL] [Abstract][Full Text] [Related]
55. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.
Bravo GL; Poje AB; Perissinotti I; Marcondes BF; Villamar MF; Manzardo AM; Luque L; LePage JF; Stafford D; Fregni F; Butler MG
Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):266-75. PubMed ID: 26590516
[TBL] [Abstract][Full Text] [Related]
56. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index.
Butler MG; Matthews NA; Patel N; Surampalli A; Gold JA; Khare M; Thompson T; Cassidy SB; Kimonis VE
Am J Med Genet A; 2019 Sep; 179(9):1826-1835. PubMed ID: 31313492
[TBL] [Abstract][Full Text] [Related]
57. Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader-Willi syndrome.
Bittel DC; Kibiryeva N; McNulty SG; Driscoll DJ; Butler MG; White RA
Am J Med Genet A; 2007 Mar; 143A(5):422-9. PubMed ID: 17036336
[TBL] [Abstract][Full Text] [Related]
58. Magel2 knockout mice manifest altered social phenotypes and a deficit in preference for social novelty.
Fountain MD; Tao H; Chen CA; Yin J; Schaaf CP
Genes Brain Behav; 2017 Jul; 16(6):592-600. PubMed ID: 28296079
[TBL] [Abstract][Full Text] [Related]
59. Hormonal and metabolic defects in a prader-willi syndrome mouse model with neonatal failure to thrive.
Stefan M; Ji H; Simmons RA; Cummings DE; Ahima RS; Friedman MI; Nicholls RD
Endocrinology; 2005 Oct; 146(10):4377-85. PubMed ID: 16002520
[TBL] [Abstract][Full Text] [Related]
60. Development of the eating behaviour in Prader-Willi Syndrome: advances in our understanding.
McAllister CJ; Whittington JE; Holland AJ
Int J Obes (Lond); 2011 Feb; 35(2):188-97. PubMed ID: 20680019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
